# Palliative Care Study in Patients With Advanced Cancer

> **NCT00127517** · PHASE2 · TERMINATED · sponsor: **Advanced Viral Research Corp**

## Conditions studied

- Cancer

## Interventions

- **DRUG:** peptide-nucleic acid solution AVR118

## Key facts

- **NCT ID:** NCT00127517
- **Lead sponsor:** Advanced Viral Research Corp
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2005-03
- **Primary completion:** —
- **Final completion:** 2006-08
- **Target enrollment:** — (—)
- **Why stopped:** Company shifted focus
- **Last updated:** 2011-06-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00127517

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00127517, "Palliative Care Study in Patients With Advanced Cancer". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT00127517. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*